Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Depta

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Plos One|June 22, 2022
Design and synthesis of Nrf2-derived hydrocarbon stapled peptides for the disruption of protein-DNA-interactionsBianca Wiedemann, Dominic Kamps, Laura Depta, et al.
ACS Central Science|January 27, 2025
Identification of a Privileged Scaffold for Inhibition of Sterol Transport Proteins through the Synthesis and Ring Distortion of Diverse, Pseudo-Natural ProductsFrederik Simonsen Bro, Laura Depta, Nienke J Dekker, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
The orientation of cholesterol's hydroxyl group affects its membrane dynamics and intracellular transportLine Lauritsen, Amanda Therese Pauli, Miklas P W Larsen, et al.
Nature Chemical Biology|June 21, 2024
Inhibition of OSBP blocks retrograde trafficking by inducing partial Golgi degradationNianzhe He, Laura Depta, Cecilia Rossetti, et al.
Chemical Science|April 19, 2019
Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase AktNiklas Uhlenbrock, Steven Smith, Jörn Weisner, et al.
Nature Chemical Biology|June 21, 2024
Orpinolide disrupts a leukemic dependency on cholesterol transport by inhibiting OSBPMarko Cigler, Hana Imrichova, Fabian Frommelt, et al.
Nature Communications|September 7, 2021
Cellular model system to dissect the isoform-selectivity of Akt inhibitorsLena Quambusch, Laura Depta, Ina Landel, et al.
RSC Medicinal Chemistry|November 24, 2025
Schweinfurthins and their analogues are highly selective cellular probes for oxysterol-binding protein (OSBP)Laura Depta, Nianzhe He, Maria Lillevang Madsen, et al.
Cancer Research|March 13, 2019
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <i>KRAS</i>-Mutant Pancreatic and Colorectal CancerJörn Weisner, Ina Landel, Christoph Reintjes, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Plos One|June 22, 2022
Design and synthesis of Nrf2-derived hydrocarbon stapled peptides for the disruption of protein-DNA-interactionsBianca Wiedemann, Dominic Kamps, Laura Depta, et al.
ACS Central Science|January 27, 2025
Identification of a Privileged Scaffold for Inhibition of Sterol Transport Proteins through the Synthesis and Ring Distortion of Diverse, Pseudo-Natural ProductsFrederik Simonsen Bro, Laura Depta, Nienke J Dekker, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
The orientation of cholesterol's hydroxyl group affects its membrane dynamics and intracellular transportLine Lauritsen, Amanda Therese Pauli, Miklas P W Larsen, et al.
Nature Chemical Biology|June 21, 2024
Inhibition of OSBP blocks retrograde trafficking by inducing partial Golgi degradationNianzhe He, Laura Depta, Cecilia Rossetti, et al.
Chemical Science|April 19, 2019
Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase AktNiklas Uhlenbrock, Steven Smith, Jörn Weisner, et al.
Nature Chemical Biology|June 21, 2024
Orpinolide disrupts a leukemic dependency on cholesterol transport by inhibiting OSBPMarko Cigler, Hana Imrichova, Fabian Frommelt, et al.
Nature Communications|September 7, 2021
Cellular model system to dissect the isoform-selectivity of Akt inhibitorsLena Quambusch, Laura Depta, Ina Landel, et al.
RSC Medicinal Chemistry|November 24, 2025
Schweinfurthins and their analogues are highly selective cellular probes for oxysterol-binding protein (OSBP)Laura Depta, Nianzhe He, Maria Lillevang Madsen, et al.
Cancer Research|March 13, 2019
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <i>KRAS</i>-Mutant Pancreatic and Colorectal CancerJörn Weisner, Ina Landel, Christoph Reintjes, et al.
Pageof 2